期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
中国沿海省份蓝碳现状与能力评估 被引量:29
1
作者 向爱 揣小伟 李家胜 《资源科学》 CSSCI CSCD 北大核心 2022年第6期1138-1154,共17页
中国海岸线总长度超过3.26万km,同时拥有红树林、盐沼、海草床3类蓝碳生态系统,且海水养殖产量常年位居世界首位,蓝碳发展条件得天独厚。本文在系统梳理国内外蓝碳研究成果的基础上,基于广义蓝碳定义,尝试从自然生态系统和海水养殖系统... 中国海岸线总长度超过3.26万km,同时拥有红树林、盐沼、海草床3类蓝碳生态系统,且海水养殖产量常年位居世界首位,蓝碳发展条件得天独厚。本文在系统梳理国内外蓝碳研究成果的基础上,基于广义蓝碳定义,尝试从自然生态系统和海水养殖系统两方面构建中国沿海省份蓝碳核算体系,基于相关统计数据、遥感数据、核算参数数据,对中国沿海省份蓝碳进行核算,分析其时空演化格局,并利用Super-SBM模型进一步对中国海水养殖碳汇渔业效率进行评估。研究表明:①中国蓝碳生态系统面积呈波动增长,1997—2019年红树林固碳量为0.033~0.078 Tg C/a,盐沼固碳量为0.234~0.646 Tg C/a,海草床固碳量为0.012~0.018 Tg C/a;②沿海九省2003—2020年的海水养殖年固碳总量为0.87~1.36 Tg C/a,省际空间差异显著,并在各时段表现出不同的增长特征;③沿海九省年蓝碳总量及结构的空间分布格局差异明显,就蓝碳能力而言,山东和福建蓝碳能力最高;就蓝碳结构而言,江苏的蓝碳构成比例较为均衡;④土地利用变化、蓝碳生态系统与海水养殖的不协调发展、气候变化等是影响蓝碳能力的重要因素,沿海九省2003—2020年的碳汇渔业效率值反映出海水养殖经济指标投入与生态环境产出存在一定失调,这也会遏制蓝碳的挖掘和利用。最后本文就蓝碳助力国家碳中和战略提出相应的优化建议。 展开更多
关键词 蓝碳生态系统 海水养殖 渔业碳汇 蓝碳能力评估 Super-SBM模型 中国沿海省份
原文传递
关于土地利用碳补偿的思考与展望 被引量:3
2
作者 蔡利民 揣小伟 +1 位作者 向爱 叶昕 《现代城市研究》 北大核心 2023年第6期2-7,16,共7页
碳中和对低碳减排与增汇固碳提出了新的要求与挑战。土地利用及其变化对生态系统的碳平衡和其承载的人为碳排放均具有重要的制约作用,优化土地利用是增汇降碳的有力手段。碳补偿是实现碳减排的有效经济措施,同时也促进不同主体和不同区... 碳中和对低碳减排与增汇固碳提出了新的要求与挑战。土地利用及其变化对生态系统的碳平衡和其承载的人为碳排放均具有重要的制约作用,优化土地利用是增汇降碳的有力手段。碳补偿是实现碳减排的有效经济措施,同时也促进不同主体和不同区域间的公平性建设。基于土地有偿使用制度,土地利用与碳补偿具有好的结合点能进一步促进碳减排。文章系统梳理了国内外在碳补偿、土地利用与碳源/汇、土地利用与低碳减排、碳排放与土地利用的公平性等方面的研究进展,总结了新时代背景下相关研究所面临的挑战,对未来的土地利用碳补偿理论、方法与应用、发展模式与路径进行了探讨与展望,并提出了相关政策建议,以期更加科学和高效地服务于增汇降碳和协调发展。 展开更多
关键词 碳补偿 土地利用 增汇降碳 土地利用碳补偿 碳中和
在线阅读 下载PDF
江苏省海洋产业碳收支核算及评价 被引量:1
3
作者 王桐 揣小伟 +2 位作者 向爱 顾云娟 别蒙 《应用生态学报》 CAS CSCD 北大核心 2023年第9期2527-2535,共9页
测算并评价海洋产业碳收支状况是在碳中和目标下促进海洋经济绿色、高效发展的基础。以江苏省为例,本研究构建了海洋产业碳收支核算体系,开展了碳效率和碳中和评估。结果表明:2016—2020年,江苏省滨海碳汇总量为89.48万~277.32万t,五大... 测算并评价海洋产业碳收支状况是在碳中和目标下促进海洋经济绿色、高效发展的基础。以江苏省为例,本研究构建了海洋产业碳收支核算体系,开展了碳效率和碳中和评估。结果表明:2016—2020年,江苏省滨海碳汇总量为89.48万~277.32万t,五大海洋产业碳排放为353.84万~435.06万t,海洋产业净碳排放为147.87万~290.61万t。5年间江苏省滨海碳汇量与碳排放量均呈增加趋势。在碳汇上,海上风电系统占比最多,其次为生态系统固碳量,海水养殖固碳量占比最小。在碳排放上,海洋交通运输业占总碳排放比重最大,其次为滨海旅游业和海洋渔业,海洋工程建筑业与海洋船舶工业碳排放占比较小。碳中和状况表现为,2016—2020年,江苏省海洋产业整体呈现碳赤字,但碳净排放量逐年减少,在碳效率上,海水养殖净碳汇效率低于全国平均水平,海上风电碳效率较为稳定。 展开更多
关键词 碳中和 蓝碳 碳收支 海洋经济 江苏省
原文传递
严格?-对角占优矩阵线性互补问题解的一个新误差界 被引量:1
4
作者 向爱 莫宏敏 《铜仁学院学报》 2018年第6期112-115,共4页
利用严格α-对角占优矩阵的定义,将该特殊矩阵分裂成严格对角占优矩阵和对角矩阵的差,根据H-矩阵的性质得到严格α-对角占优矩阵线性互补问题解的新误差界,并用数值算例验证了新误差界的可行性和有效性。
关键词 α-对角占优 误差界 线性互补问题
在线阅读 下载PDF
Clinico-pathological characteristics and prognosis of young women with breast
5
作者 Juan Xu Ling-Fan Li +4 位作者 Hua-Lin Xiao Jun-Cheng Li Sheng-Dong He xiang ai Peng Sun 《Cancer Advances》 2023年第8期1-6,共6页
Background:Breast cancer is more common among young women in China than in developed countries.This study analyzes the clinicopathological features and prognosis of young women with breast cancer in southwest China.Ma... Background:Breast cancer is more common among young women in China than in developed countries.This study analyzes the clinicopathological features and prognosis of young women with breast cancer in southwest China.Materials and Methods:We reviewed the records of 406 breast cancer patients≤35 years old from 2008 to 2017 in southwest China,investigating their biological characteristics and prognosis.Results:In southwest China,8.77%of breast cancer patients were young women.Although the number of breast cancer cases increased over time,the proportion of young women declined.Patients in stages III and IV accounted for 32%of cases.Young women with breast cancer often experienced local and regional recurrence and had a poor prognosis(5-year disease-free survival rate of 54.9%and 5-year overall survival rate of 71.3%).T and N stages were significantly related to disease-free survival and overall survival.Hormone receptor status was associated with overall survival.Conclusions:In southwest China,young women with breast cancer tend to present with late-stage clinical features,and the prognosis remains poor. 展开更多
关键词 breast cancer young women clinicopathological features PROGNOSIS
暂未订购
Effectiveness of Ultrasound-Guided Vacuum-Assisted Excision for Treating Benign Breast Lesions
6
作者 Xuanni Tan Juncheng Xuhong +5 位作者 xiang ai Qin Niu Jing Liu Yi Zhang Xiaowei Qi Jun Jiang 《Cancer Innovation》 2025年第1期70-78,共9页
Background:Ultrasound‑guided vacuum-assisted excision(UGVAE)and breast biopsy are widely used for the diagnosis and treatment of both benign and suspicious breast lesions.In this retrospective study,we aimed to determ... Background:Ultrasound‑guided vacuum-assisted excision(UGVAE)and breast biopsy are widely used for the diagnosis and treatment of both benign and suspicious breast lesions.In this retrospective study,we aimed to determine the safety of UGVAE for benign breast lesions and provide guidance for clinical practice.Methods:We analyzed clinical and pathological data of female patients who had undergone UGVAE between January 2015 and December 2017 at our institution.All breast lesions were categorized according to the Breast Imaging Reporting and Data System(BI-RADS)before performing UGVAE.Results:In our study cohort,UGVAE was used to resect 10,378 breast lesions from 5789 patients,and selected clinical and histopathological data were analyzed.The most common adverse events were postoperative bleeding(0.24%)and skin hypersensitivity(0.67%).The residual lesion rate was 2.27%.Fibroadenomas accounted for most of the benign lesions(7932 of 10,193;77.82%).Breast cancer was diagnosed in 150 lesions from 128 patients.Multivariable binary logistic regression analyses showed that older age(odds ratio[OR]=2.034,95%confidence interval[CI]:1.668–2.480,p<0.001),higher BI-RADS category(OR=9.514,95%CI:6.790–13.332,p<0.001),and larger legion size(OR=1.048,95%CI:1.019–1.077,p=0.001)were associated with an increased likelihood of breast cancer.Ninety-six patients with breast cancer had undergone follow-up treatment,achieving a 3-year disease-free survival rate of 97.2%and a 3-year overall survival rate of 100%.Conclusions:UGVAE is a safe and effective means of removing benign breast lesions,causing minimal postoperative trauma and fewer complications compared with open surgery.Moreover,UGVAE had little impact on the follow-up treatment and survival of patients diagnosed with breast cancer. 展开更多
关键词 benign breast disease BI-RADS breast cancer ultrasound‑guided vacuum-assisted excision
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部